BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients-Reference-Cited by-同舟云学术

BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients

Published:2017-04 Issue:1 Volume:145 Page:137-141
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Eoh Kyung Jin^ORCID,Park Ji Soo,Park Hyung Seok,Lee Seung-Tae,Han Jeongwoo,Lee Jung-Yun,Kim Sang Wun^ORCID,Kim Sunghoon,Kim Young Tae,Nam Eun Ji

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference23 articles.

1. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium;Easton;Am. J. Hum. Genet.,1993

2. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2;Parmigiani;Am. J. Hum. Genet.,1998

3. The BOADICEA model of genetic susceptibility to breast and ovarian cancer;Antoniou;Br. J. Cancer,2004

4. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals;Frank;J. Clin. Oncol.,2002

5. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO;Evans;J. Med. Genet.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib;European Urology;2023-03

2. The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study;Expert Review of Molecular Diagnostics;2023-01-02

3. RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma;Journal of Gynecologic Oncology;2023

4. BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors;British Journal of Cancer;2022-04-30

5. The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population;International Journal of General Medicine;2022-03